NovaBay Pharmaceuticals, Inc. Logo

NovaBay Pharmaceuticals, Inc.

Develops and commercializes eyecare, skincare, and wound care products.

NBY | US

Overview

Corporate Details

ISIN(s):
US66987P2011
LEI:
Country:
United States of America
Address:
2000 POWELL STREET, SUITE 1150, 94608 EMERYVILLE

Description

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company that develops and commercializes scientifically-created and clinically-proven products for the eyecare, skincare, and wound care markets. The company's core technology is a proprietary, stable formulation of hypochlorous acid. Its leading product is Avenova®, an antimicrobial lid and lash solution available over-the-counter for eye hygiene. In the wound care sector, NovaBay manufactures and sells products under the NeutroPhase® and PhaseOne® brands, which utilize its hypochlorous acid technology to aid in cleansing and debridement. The company focuses on providing accessible, problem-solving solutions for improved well-being.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all NovaBay Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NovaBay Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NovaBay Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

GlaxoSmithKline PLC Logo
A global biopharma company developing medicines and vaccines to prevent and treat disease.
United Kingdom
GSK
GL Pharm Tech Corp. Logo
Develops incrementally modified drugs using advanced drug delivery technologies.
South Korea
204840
GNI  Group Ltd. Logo
Multinational biopharma firm developing drugs, TCMs, and medical devices.
Japan
2160
Goodwill Pharma Plc Logo
Develops, manufactures, and distributes medicines, supplements, and medical devices.
Hungary
GWPH
Gossamer Bio, Inc. Logo
Clinical-stage biopharma developing an inhaled therapy for pulmonary hypertension.
United States of America
GOSS
Grace Therapeutics, Inc. Logo
Late-stage biopharma developing drugs for rare and orphan neurological conditions.
United States of America
GRCE
Green Cross Corporation Logo
Develops protein therapeutics, vaccines, diagnostics, and consumer health products.
South Korea
006280
A holding company in biopharma, diagnostics, consumer, and digital healthcare.
South Korea
005250
GREEN CROSS WellBeing Corporation Logo
Develops nutritional injections, health supplements, and cosmetics.
South Korea
234690
Greenwich LifeSciences, Inc. Logo
A clinical-stage biopharma developing immunotherapies to prevent cancer recurrence.
United States of America
GLSI

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.